These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 4946453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Biogenic amines (cerebral or cellular localization, influence of various chemical factors)].
    Schrammowa H, Rybakowski J.
    Psychiatr Pol; 1972; 6(1):73-9. PubMed ID: 4622259
    [No Abstract] [Full Text] [Related]

  • 4. Involvement of biogenic amines in memory formation.
    Dismukes RK, Rake AV.
    Psychopharmacologia; 1972; 23(1):17-25. PubMed ID: 4259732
    [No Abstract] [Full Text] [Related]

  • 5. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA.
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Biogenic amines in the pathogenesis of different forms of viral infections].
    Popenenkova ZA, Maslennikov GA.
    Vestn Akad Med Nauk SSSR; 1977; (7):83-92. PubMed ID: 197741
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG, Scotti de Carolis A, Liuzzi A, Massotti M.
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Indolealkylamines and behavior.
    Airaksinen MM, McIsaac WM.
    Ann Med Exp Biol Fenn; 1968; 46(3):367-81. PubMed ID: 4896939
    [No Abstract] [Full Text] [Related]

  • 15. Neuropsychopharmacology and the affective disorders. (Third of three parts).
    Schildkraut JJ.
    N Engl J Med; 1969 Aug 07; 281(6):302-8 concl. PubMed ID: 4894568
    [No Abstract] [Full Text] [Related]

  • 16. 'Hallucinogenic drugs and central transmitter substances'.
    Leonard BE.
    Int J Neurosci; 1972 Jul 07; 4(1):35-43. PubMed ID: 4348844
    [No Abstract] [Full Text] [Related]

  • 17. Biogenic amines and affective disorders.
    Schildkraut JJ.
    Annu Rev Med; 1974 Jul 07; 25(0):333-48. PubMed ID: 4368455
    [No Abstract] [Full Text] [Related]

  • 18. [Schizophrenia and cerebral amines].
    Véron JP, Kezirian S.
    Presse Med (1893); 1971 Oct 23; 79(44):1973-4. PubMed ID: 5119550
    [No Abstract] [Full Text] [Related]

  • 19. Effect of four amphetamines on brain biogenic amines and their metabolites.
    Leonard BE.
    Biochem Pharmacol; 1972 May 01; 21(9):1289-97. PubMed ID: 5038674
    [No Abstract] [Full Text] [Related]

  • 20. [The localization of biogenic amines in the autonomic nervous system (electron microscopic study in conjunction with autoradiography)].
    Taksi Zh, Droz B.
    Arkh Anat Gistol Embriol; 1968 Jul 01; 55(7):35-42. PubMed ID: 5303118
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.